Latest MRTX reports update at 2023-11-06: 2023-Q3 ∙ 2022-Q4 ∙ 2022-Q3
  1. Home
  2. Stock quotes
  3. Mirati Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Mirati Therapeutics logo
Mirati Therapeutics MRTX
$ 58.7 0.0%
mail-toReport an Error

Mirati Therapeutics EV/EBITDA Ratio 2011-2024 | MRTX

Annual EV/EBITDA Ratio Mirati Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-12.9 -24.7 -14.5 -19.4 -7.53 -0.928 -4.87 -7.08 -7.05 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.928 -24.7 -11